高级检索
当前位置: 首页 > 详情页

Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Max Delbruck Ctr Mol Med MDC, Cellular Neurosci, Berlin, Germany [2]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept Neurosurg,Wuhan 430074,Peoples R China [3]Charite, Dept Neurol, Charitepl 1, D-13353 Berlin, Germany [4]Charite, Dept Expt Neurol, Ctr Stroke Res Berlin, Dept Neurol, Charitepl 1, D-13353 Berlin, Germany [5]Charite, Inst Cell Biol & Neurobiol, Ctr Anat, Charitepl 1, D-13353 Berlin, Germany [6]Univ Schleswig Holstein, Dept Neurosurg, Campus Kiel, Kiel, Germany
出处:
ISSN:

关键词: Glioma Glioma-associated microglia brain macrophages Glioma stem cells IL-6 Toll-like receptor 4

摘要:
Peripheral macrophages and resident microglia constitute the dominant glioma-infiltrating cells. The tumor induces an immunosuppressive and tumor-supportive phenotype in these glioma-associated microglia/brain macrophages (GAMs). A subpopulation of glioma cells acts as glioma stem cells (GSCs). We explored the interaction between GSCs and GAMs. Using CD133 as a marker of stemness, we enriched for or deprived the mouse glioma cell line GL261 of GSCs by fluorescence-activated cell sorting (FACS). Over the same period of time, 100 CD133(+) GSCs had the capacity to form a tumor of comparable size to the ones formed by 10,000 CD133(-) GL261 cells. In IL-6(-/-) mice, only tumors formed by CD133(+) cells were smaller compared with wild type. After stimulation of primary cultured microglia with medium from CD133-enriched GL261 glioma cells, we observed an selective upregulation in microglial IL-6 secretion dependent on Toll-like receptor (TLR) 4. Our results show that GSCs, but not the bulk glioma cells, initiate microglial IL-6 secretion via TLR4 signaling and that IL-6 regulates glioma growth by supporting GSCs. Using human glioma tissue, we could confirm the finding that GAMs are the major source of IL-6 in the tumor context.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 2 区 医学
小类 | 2 区 临床神经病学 2 区 病理学 3 区 神经科学
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 病理学 4 区 临床神经病学 4 区 神经科学
JCR分区:
出版当年[2014]版:
Q1 PATHOLOGY Q1 CLINICAL NEUROLOGY Q2 NEUROSCIENCES
最新[2023]版:
Q2 CLINICAL NEUROLOGY Q2 NEUROSCIENCES Q2 PATHOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者单位: [1]Max Delbruck Ctr Mol Med MDC, Cellular Neurosci, Berlin, Germany
通讯作者:
通讯机构: [1]Max Delbruck Ctr Mol Med MDC, Cellular Neurosci, Berlin, Germany [*1]Max Delbruck Ctr Mol Med, Cellular Neurosci, Robert Rossle Str 10, D-13125 Berlin, Germany
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:0 总访问量:410 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)